We have been using statins to reduce perioperative cardiac events on the inpatient service for quite a while. The reality is, the data on its use in this situation is sparse. The best study is too small and didn’t actually reach statistical significance (although a trend towards benefit) (Lipitor with Vascular Surgery.pdf). It was also studied on patients undergoing vascular surgeries, not in grandpa’s hip replacement.